Published on 3 Aug 2022 on Bloomberg via Yahoo Finance
(Bloomberg) -- CVS Health Corp. rose the most since late 2020 after increasing its 2022 earnings outlook and beating analysts’ expectations for second-quarter profit as rising sales of over-the-counter Covid-19 tests helped its drugstore chain withstand fading demand for vaccines and laboratory diagnostics.
Most Read from Bloomberg
This Is How China Could Hit Back Over Pelosi’s Taiwan VisitSneakerhead Accused of Running Huge Air Jordan Ponzi SchemeChina Warns Airlines to Avoid ‘Danger Zones’ Around Taiwan